EPI-7170 - HY-150102
Nur noch %1 verfügbar
Catalog #
HY-150102
Ab
289,00 €
EPI-7170, a ralaniten analogue, is a potent androgen receptor N-terminal structural domain antagonist that blocks the transcriptional activity of full-length AR (FL-AR) and AR splice variants (AR-Vs). EPI-7170 has antitumor effects against enzalutamide resistant castration-resistant prostate cancer (CRPC)[1].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-150102/EPI-7170-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Room Temperature |
| Application | Cancer-programmed cell death |
| CAS | 2139288-26-7 |
| Storage | 4°C (Powder, sealed storage, away from moisture) |
| MWT | 540.88 |
| Solubility | DMSO : 100 mg/mL (ultrasonic) |
| Clinical Information | No Development Reported |
| Target | Androgen Receptor |
| Application: | Cancer-programmed cell death |
|---|